6篇
您的检索式：作者名="FRANCESCO PETRELLA"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Superior Vena Cava Resection for Lung and Mediastinal Malignancies: A Single-Center Experience With 70 Cases显示文摘 | Lorenzo Spaggiari Francesco Leo Giulia Veronesi Piergiorgio Solli Domenico Galetta Brunilda Tatani Francesco Petrella Davide Radice | 2007 | The Annals of Thoracic Surgery2007，，1： | 3 |
| 2 | Sensorless speed control of a PM synchronous motor by sliding mode observer 显示文摘 | Francesco Parasiliti Roberto Petrella Marco Tursini | 1997 | Proceedings of ISIE1997，3，： | 1 |
| 3 | Ini tial Rotor Position Estimation Method for PM Motors显示文摘 | Marco Tursini Roberto Petrella Francesco Parasiliti | 2003 | IEEE Transaction on Induatry Applications2003，39，6： | 1 |
| 4 | Percutaneous vertebroplasty in 1,253 levels: results and long-term effectiveness in a single centre显示文摘 | Salvatore Masala Roberta Mastrangeli Maria Chiara Petrella Francesco Massari Antonio Ursone Giovanni Simonetti | 2009 | European Radiology2009，，1： | 1 |
| 5 | Initial rotor po- sition estimation method for PM motors 显示文摘 | Marco Tursini Roberto Petrella Francesco Parasiliti | 2003 | IEEE Transactions on Industry Applications2003，39，6： | 1 |
| 6 | Stem cell technology for antitumor drug loading and delivery in oncology显示文摘The main aim of antineoplastic treatment is to maximize patient benefit by augmenting the drug accumulation within affected organs and tissues,thus incrementing drug effects and,at the same time,reducing the damage of non-involved tissues to cytotoxic agents.Mesenchymal stromal cells(MSC)represent a group of undifferentiated multipotent cells presenting wide self-renewal features and the capacity to differentiate into an assortment of mesenchymal family cells.During the last year,they have been proposed as natural carriers for the selective release of antitumor drugs to malignant cll,s thus optimizing cytotoxic action on cancer cll,while significantly reducing adverse side efect on healthy cells.MSC chemotherapeutic drug loading and delivery is an encouraging new area of cell therapy for several tumors,especially for those with unsatisfactory prognosis and limited treatment options available.Although some experim ental models have been sucesfuly developed,phase I dinical studies are needed to confirm this potential application of cell therapy,in particular in the case of primary and secondary lung cancers. | FRANCESCO PETRELLA ENRICO MARIO CASSINA LIDIA LIBRETTI EMANUELE PIRONDINI FEDERICO RAVEGLIA ANTONIO TUORO | 2024 | Oncology Research2024，32，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员